Royal Bank Of Canada Oncolytics Biotech Inc Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 63,682 shares of ONCY stock, worth $43,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,682
Previous 74,546
14.57%
Holding current value
$43,940
Previous $64,000
7.81%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ONCY
# of Institutions
47Shares Held
1.3MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL200KShares$138,2760.02% of portfolio
-
Seeds Investor LLC New York, NY190KShares$131,0590.05% of portfolio
-
Goldman Sachs Group Inc New York, NY101KShares$69,9640.0% of portfolio
-
Virtu Financial LLC New York, NY98.5KShares$67,9310.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.9KShares$46,1870.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $39.9M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...